Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Ranibizumab is a monoclonal antibody fragment obtained from the same parental murine antibody as bevacizumab. It is an anti-angiogenic drug that has been approved for the treatment of AMD patients.
This report presents a comprehensive overview, market shares and growth opportunities of Ranibizumab market by product type, application, key companies and key regions. Biomedicine has achieved rapid growth in the global pharmaceutical market due to its high pharmacological activity, strong specificity, and good therapeutic effect. In the biopharmaceutical market, the monoclonal antibody is the most subdivided category. With the development of biotechnology, the research on monoclonal antibodies will be further deepened, and the patients' demand for monoclonal antibodies will also be further increased. Ranibizumab is mainly used for the treatment of age-related macular degeneration (AMD), a retinal disease that increases the incidence with age and causes a significant decrease in vision. Diabetic retinopathy and diabetic macular edema can also be treated with ranibizumab. Therefore, the deepening of global aging and the increasing incidence of chronic diseases such as diabetes will promote the expansion of demand for ranibizumab.
Indian pharmaceutical company Intas Pharmaceuticals has launched RAZUMAB™, a biosimilar of Lucentis® (Ranibizumab). The product is entirely manufactured in India, and the price of RAZUMAB™ is much cheaper than Lucentis®, which will allow the drug to be used in a wider patient population.
This report elaborates on the current development of the Ranibizumab industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Genentech
Novartis
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Single-use prefilled syringe
Single-use glass vial
Application:
AMD
Diabetic Retinopathy (DR)
Diabetic Macular Edema (DME)
mCNV
RVO
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Ranibizumab Industry Overview
-
1.1.1 Ranibizumab Market Scope and Market Segments
-
1.1.2 Ranibizumab Industry Characteristics
-
1.1.3 Global and China Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Ranibizumab Production Value and Growth Rate (2017-2028)
-
1.2 Global Ranibizumab Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Single-use prefilled syringe
-
1.2.2 Single-use glass vial
-
1.3 Global Ranibizumab Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 AMD
-
1.3.2 Diabetic Retinopathy (DR)
-
1.3.3 Diabetic Macular Edema (DME)
-
1.3.4 mCNV
-
1.3.5 RVO
-
1.4 Market Analysis by Region
-
1.4.1 North America Ranibizumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Ranibizumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Ranibizumab Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Ranibizumab Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Ranibizumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Ranibizumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Ranibizumab Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Ranibizumab Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Ranibizumab Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Ranibizumab Industry Porter's Five Forces Model Analysis
-
2.2.3 Ranibizumab Industry PEST Analysis
-
2.3 Ranibizumab Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Ranibizumab Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Ranibizumab Industry
Chapter 3 Global and China Ranibizumab Market, by Manufacturer
-
3.1 Global and China Ranibizumab Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Ranibizumab Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Ranibizumab Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Ranibizumab Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Ranibizumab Market Top 3 Players
Chapter 4 Global and China Ranibizumab Market, by Type (2017-2028)
-
4.1 Ranibizumab Market Trend, by Type
-
4.2 Global Ranibizumab Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Ranibizumab Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Ranibizumab Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Ranibizumab Price Trend, by Type (2017-2028)
-
4.3 China Ranibizumab Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Ranibizumab Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Ranibizumab Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Ranibizumab Price Trend, by Type (2017-2028)
Chapter 5 Global and China Ranibizumab Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Ranibizumab Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Ranibizumab Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Ranibizumab Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Ranibizumab Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Ranibizumab Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Ranibizumab Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Ranibizumab Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Ranibizumab Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Ranibizumab Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Ranibizumab Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Ranibizumab Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Ranibizumab Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Ranibizumab Market Analysis
-
7.1 North America Ranibizumab Market, by Type
-
7.2 North America Ranibizumab Market, by Application
-
7.3 North America Ranibizumab Market Analysis and Forecast, by Country
-
7.3.1 United States Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Ranibizumab Market Analysis
-
8.1 Europe Ranibizumab Market, by Type
-
8.2 Europe Ranibizumab Market, by Application
-
8.3 Europe Ranibizumab Market Analysis and Forecast, by Country
-
8.3.1 Germany Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Ranibizumab Market Analysis
-
9.1 APAC Ranibizumab Market, by Type
-
9.2 APAC Ranibizumab Market, by Application
-
9.3 APAC Ranibizumab Market Analysis and Forecast, by Country
-
9.3.1 China Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Ranibizumab Market Analysis
-
10.1 Latin America, Middle East and Africa Ranibizumab Market, by Type
-
10.2 Latin America, Middle East and Africa Ranibizumab Market, by Application
-
10.3 Latin America, Middle East and Africa Ranibizumab Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Ranibizumab Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Ranibizumab Company Profiles
-
11.1 Genentech
-
11.1.1 Genentech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Genentech Ranibizumab Product Profiles, Application and Specification
-
11.1.3 Genentech Ranibizumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Novartis
-
11.2.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Novartis Ranibizumab Product Profiles, Application and Specification
-
11.2.3 Novartis Ranibizumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Ranibizumab Industry Investment Prospect and Risk Assessment
-
12.1 Ranibizumab Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Ranibizumab Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure China Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Global Ranibizumab Production Value and Growth Rate (2017-2028)
-
Figure China Ranibizumab Production Value and Growth Rate (2017-2028)
-
Figure Global Ranibizumab Market Size and Growth Rate of Single-use prefilled syringe (2017-2028)
-
Figure Global Ranibizumab Market Size and Growth Rate of Single-use glass vial (2017-2028)
-
Figure Global Ranibizumab Market Size and Growth Rate of AMD (2017-2028)
-
Figure Global Ranibizumab Market Size and Growth Rate of Diabetic Retinopathy (DR) (2017-2028)
-
Figure Global Ranibizumab Market Size and Growth Rate of Diabetic Macular Edema (DME) (2017-2028)
-
Figure Global Ranibizumab Market Size and Growth Rate of mCNV (2017-2028)
-
Figure Global Ranibizumab Market Size and Growth Rate of RVO (2017-2028)
-
Figure North America Ranibizumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Ranibizumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Ranibizumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Ranibizumab Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Ranibizumab Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Ranibizumab Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Ranibizumab Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Ranibizumab Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Ranibizumab Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Ranibizumab Market Share, by Manufacturer in 2021
-
Figure Global and China Ranibizumab Market Share, by Manufacturer in 2022
-
Table Global Ranibizumab Sales Volume, by Type (2017-2028)
-
Table Global Ranibizumab Sales Volume Share, by Type (2017-2028)
-
Figure Global Ranibizumab Sales Volume Share, by Type (2017-2028)
-
Table Global Ranibizumab Sales Value, by Type (2017-2028)
-
Table Global Ranibizumab Sales Value Share, by Type (2017-2028)
-
Figure Global Ranibizumab Price Trend, by Type (2017-2028)
-
Table China Ranibizumab Sales Volume, by Type (2017-2028)
-
Table China Ranibizumab Sales Volume Share, by Type (2017-2028)
-
Figure China Ranibizumab Sales Volume Share, by Type (2017-2028)
-
Table China Ranibizumab Sales Value, by Type (2017-2028)
-
Table China Ranibizumab Sales Value Share, by Type (2017-2028)
-
Figure China Ranibizumab Price Trend, by Type (2017-2028)
-
Table Global Ranibizumab Sales Volume, by Application (2017-2028)
-
Table Global Ranibizumab Sales Volume Share, by Application (2017-2028)
-
Figure Global Ranibizumab Sales Volume Share, by Application (2017-2028)
-
Table Global Ranibizumab Sales Value, by Application (2017-2028)
-
Table Global Ranibizumab Sales Value Share, by Application (2017-2028)
-
Figure Global Ranibizumab Sales Value Share, by Application (2017-2028)
-
Table China Ranibizumab Sales Volume, by Application (2017-2028)
-
Table China Ranibizumab Sales Volume Share, by Application (2017-2028)
-
Figure China Ranibizumab Sales Volume Share, by Application (2017-2028)
-
Table China Ranibizumab Sales Value, by Application (2017-2028)
-
Table China Ranibizumab Sales Value Share, by Application (2017-2028)
-
Figure China Ranibizumab Sales Value Share, by Application (2017-2028)
-
Figure China Ranibizumab Production, Import, Consumption and Export (2017-2022)
-
Figure North America Ranibizumab Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Ranibizumab Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Ranibizumab Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Ranibizumab Production, Import, Consumption and Export (2017-2022)
-
Table North America Ranibizumab Sales Volume, by Type (2017-2028)
-
Table North America Ranibizumab Sales Volume Share, by Type (2017-2028)
-
Figure North America Ranibizumab Sales Volume Share, by Type (2017-2028)
-
Table North America Ranibizumab Sales Volume, by Application (2017-2028)
-
Table North America Ranibizumab Sales Volume Share, by Application (2017-2028)
-
Figure North America Ranibizumab Sales Volume Share, by Application (2017-2028)
-
Figure United States Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure United States Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure Canada Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Table Europe Ranibizumab Sales Volume, by Type (2017-2028)
-
Table Europe Ranibizumab Sales Volume Share, by Type (2017-2028)
-
Figure Europe Ranibizumab Sales Volume Share, by Type (2017-2028)
-
Table Europe Ranibizumab Sales Volume, by Application (2017-2028)
-
Table Europe Ranibizumab Sales Volume Share, by Application (2017-2028)
-
Figure Europe Ranibizumab Sales Volume Share, by Application (2017-2028)
-
Figure Germany Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure UK Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure UK Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure France Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure France Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure Italy Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure Spain Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure Poland Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure Russia Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Table APAC Ranibizumab Sales Volume, by Type (2017-2028)
-
Table APAC Ranibizumab Sales Volume Share, by Type (2017-2028)
-
Figure APAC Ranibizumab Sales Volume Share, by Type (2017-2028)
-
Table APAC Ranibizumab Sales Volume, by Application (2017-2028)
-
Table APAC Ranibizumab Sales Volume Share, by Application (2017-2028)
-
Figure APAC Ranibizumab Sales Volume Share, by Application (2017-2028)
-
Figure China Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure China Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure Japan Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure India Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure India Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Ranibizumab Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Ranibizumab Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Ranibizumab Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Ranibizumab Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Ranibizumab Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Ranibizumab Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Ranibizumab Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Ranibizumab Sales Value and Growth Rate (2017-2028)
-
Table Genentech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Genentech Product Profiles, Application and Specification
-
Table Genentech Ranibizumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Ranibizumab Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
